Advertisement

Topics

ADVANCED VIRAL RESEARCH CORP Company Profile

15:01 EDT 20th September 2018 | BioPortfolio

Advanced Viral Research Corp. (OTC Bulletin Board: ADVR), established in the mid-1980s, and headquartered in Yonkers, New York, is a biopharmaceutical firm dedicated to improving patients' lives by researching, developing, and bringing to market new and effective therapies for many serious diseases and disorders. With the commitment of expert leadership and skilled research scientists, ADVR is aggressively working to bring its flagship product, AVR118, to patients. A real blockbuster potential exists for this new type of biopolymer chemistry, which possesses novel immunomodulator activity. This peptide-nucleic acid complex, which to date has demonstrated a very favorable safety profile, appears to stimulate the pro-inflammatory response required to combat viral infections, such as HIV; and to dampen aberrant autoimmune-type inflammatory responses, which often occur in diseases such as rheumatoid arthritis. In December 2004 ADVR announced an IND approval for AVR118 by the United States Food and Drug Administration. This allows the company to conduct a Phase II clinical trial in the United States. The study will examine the safety, tolerability, and efficacy of AVR118 in patients with advanced cancer who are suffering from symptoms of progressive disease. In addition, in January 2005 the company announced the final results of its Phase I/II clinical trial of AVR118 in patients with AIDS, which was conducted in Israel at the Kaplan Medical Center. The study results showed that AVR118 continues to demonstrate evidence of unique patient benefits, a favorable safety profile, and no apparent drug-related adverse events. Advanced Viral Research Corp. has about 17,000 square feet of office, laboratory and pilot manufacturing space at its headquarters. In addition to 12 patents, ADVR currently has applications for well over 20 additional patents related to AVR118, and continues to submit applications for additional patents.

Location

200 CORPORATE BLVD. SOUTH
YONKERS
10701
United States of America

Contact

Phone: 914.376.7383
Fax: 914.376.7368
Email: staff@equityrelations.com


News Articles [974 Associated News Articles listed on BioPortfolio]

#jobs #lifescience Postdoctoral Researcher on Viral Oncology

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Postdoctoral Researcher on Viral Oncology .A postdoctoral research position i...

People who don’t read the news better at predicting which articles will go viral

Figuring out how to make articles and videos go viral is the holy grail for any content creator. Although a magic formula remains elusive, in recent years, neuroscientists have forecasted which conten

#jobs #lifescience Paramount Recruitment: Viral Vector Scientist – AAV- Oxford

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Paramount Recruitment: Viral Vector Scientist – AAV- Oxford . Negotiabl...

Korea Investment CORP Boosts Stake in Mylan

Korea Investment CORP grew its position in Mylan by 462.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 736,474 shar...

Risk Factors for Advanced Fibrosis After SVR in Chronic HCV

This study investigated the long-term effect of achieved SVR on liver fibrosis in a cohort with pretreatment advanced chronic HCV infection. What risk factors are associated with persisting fibrosis? ...

#jobs #lifescience Paramount Recruitment: Viral Vector Engineering Scientist – Oxford

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Paramount Recruitment: Viral Vector Engineering Scientist – Oxford . Ne...

Viruses not linked to asthma exacerbation severity

1. Identified viral pathogens were not associated with asthma exacerbation severity, but were linked to increased treatment failure. Evidence Rating Level: 2 (Good) Study Rundown: Viral and bacterial ...

#jobs #lifescience Paramount Recruitment: Viral Vector Scientist- Lentiviral – Oxford

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Paramount Recruitment: Viral Vector Scientist- Lentiviral – Oxford . Ne...

PubMed Articles [2719 Associated PubMed Articles listed on BioPortfolio]

Recent trends in click chemistry as a promising technology for virus-related research.

Click chemistry involves reactions that were originally introduced and used in organic chemistry to generate substances by joining small units together with heteroatom linkages (C-X-C). Over the last ...

What is real success in nursing research?

Who and what can define what success is in research? With the United Kingdom's seven-yearly Research Excellence Framework and recent anniversaries such as the 40 of the Journal of Advanced Nursing pro...

Non-Viral Based miR Delivery and Recent Developments.

miRNAs are promising therapeutic targets or tools for the treatment of numerous diseases, with most prominently, cancer. The inherent capacity of these short nucleic acids to regulate multiple cancer-...

Factors improving the utility of anti-viral therapy for chronic hepatitis B: a nationwide multi-center study in Japan.

The consideration of patients' needs in terms of research outcomes is emphasized in research promotion to eradicate hepatitis B virus according to the Basic Act on Hepatitis Measures in Japan. This st...

Double and Mutations in Surgically Treated Colorectal Cancer Liver Metastases: An International, Multi-institutional Case Series.

While previously believed to be mutually exclusive, concomitant mutation of Kirsten rat sarcoma viral oncogene homolog (KRAS)- and V-raf murine sarcoma b-viral oncogene homolog B1 (BRAF)-mutated color...

Clinical Trials [7154 Associated Clinical Trials listed on BioPortfolio]

Third Party Anti-Viral Cytotoxic T-Cells

The purpose of this study is to demonstrate that viral specific T-cells (a type of white blood cell) can be generated from an unrelated donor and given safely to patients with viral infect...

Specimens From Normal Controls

The Viral Epidemiology Branch (VEB) of the National Cancer Institute (NCI) conducts research on viral infections and their associations with various diseases including AIDS and cancer. For...

CNS Viral Dynamics and Cellular Immunity During AIDS

Understanding whether or not viral replication occurs in the brain during chronic untreated HIV-1 infection is of undeniable importance, and has implications for treatment and research pri...

Relationship of Viral Resistance Development to CD4 Monitoring Alone or With Viral Load Monitoring

This study will examine whether HIV-infected patients are more likely to develop resistance to antiretroviral therapy if their blood is not monitored for the number of viruses (viral load)...

FST-100 in the Treatment of Acute Viral Conjunctivitis

This randomized, double masked, multi-center study is being conducted to support the safety and efficacy of FST-100 for the treatment of acute viral conjunctivitis. The study intends to sh...

Companies [2293 Associated Companies listed on BioPortfolio]

ADVANCED VIRAL RESEARCH CORP

Advanced Viral Research Corp. (OTC Bulletin Board: ADVR), established in the mid-1980s, and headquartered in Yonkers, New York, is a biopharmaceutical firm dedicated to improving patients' lives by re...

Biomagnetics Diagnostics Corporation

Biomagnetics Diagnostics Corporation is an advanced medical device and biotechnology company and an acquirer other innovative technologies. The Company’s revolutionary diagno...

Virus Detection & Diagnostics Virinova

Our unique and proprietory diagnostic technology enables the detection and quantification of viruses without the use of PCR or antibodies - Direct detection of viruses and viral particles - F...

TanTec Biosystems, Inc.

TanTec Biosystems is a privately held biotechnology company actively engaged in the development and manufacture of sensitive and dependable biomedical standards for use in virology research and the cr...

Viral Antigens, Inc

VIRAL ANTIGENS, INC. was founded in September of 1982 to commercialize techniques for producing high quality antigens and viral components and attaching them to latex beads. Research on rubella virus ...

More Information about "ADVANCED VIRAL RESEARCH CORP" on BioPortfolio

We have published hundreds of ADVANCED VIRAL RESEARCH CORP news stories on BioPortfolio along with dozens of ADVANCED VIRAL RESEARCH CORP Clinical Trials and PubMed Articles about ADVANCED VIRAL RESEARCH CORP for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ADVANCED VIRAL RESEARCH CORP Companies in our database. You can also find out about relevant ADVANCED VIRAL RESEARCH CORP Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record